Keros Therapeutics, Inc. (KROS)

SEC filing

Keros Therapeutics, Inc.

KROS · CIK 1664710

4 · Aug 20, 2026 · Corp. Controller & VP, Finance Tanini Annita sold 1,224 shares at $10.29/share ($12,595)

Corp. Controller & VP, Finance Tanini Annita sold 1,224 shares at $10.29/share ($12,595)

xslF345X06/form4-08202026_040808.xml

xslF345X06/form4-08202026_040808.xmlSEC.gov

Graphics and non-inline formats (not embedded below).